文献速递复苏、休克与脓毒症儿科与产科急症重症综合管理与镇静镇痛

机器学习推导四种可计算的24小时儿童脓毒症表型以促进早期个体化抗炎临床试验入组

Machine learning derivation of four computable 24-h pediatric sepsis phenotypes to facilitate enrollment in early personalized anti-inflammatory clinical trials.
PubMed 文献 · Crit Care · 2022-05-07
一句话结论基于404例儿童脓毒症数据,机器学习推导出四种24小时可计算表型,其中PedSep-D表型发生TAMOF和MAS风险最高,适合作为早期个体化抗炎试验的入组人群。

该研究应用共识k-means聚类分析对PHENOMS队列404例儿童脓毒症数据进行分析,使用25个床旁变量(包括C反应蛋白和铁蛋白)推导24小时可计算表型。结果得出四种表型(PedSep-A、B、C、D),其中PedSep-D患者(n=56,死亡率34%)肌酐和器官衰竭数量最高,包括肾、肝和血液系统器官衰竭,血小板计数最低,发生TAMOF的校正OR为47.51(95%CI 18.83-136.83,p<0.0001),发生MAS的校正OR为38.63(95%CI 13.26-137.75,p<0.0001)。结论认为PedSep-D表型最适合入组针对TAMOF和MAS的早期个体化抗炎试验,并提供了计算机工具用于识别个体患者表型归属。

要点

  • 在404例儿童脓毒症队列中推导出四种24小时可计算表型(PedSep-A至D),各表型死亡率分别为2%、12%、10%和34%。
  • PedSep-D患者(n=56)肌酐和器官衰竭数量最高,包括肾、肝和血液系统器官衰竭,血小板计数最低(p<0.05)。
  • PedSep-D发生TAMOF的校正OR为47.51(95%CI 18.83-136.83,p<0.0001),发生MAS的校正OR为38.63(95%CI 13.26-137.75,p<0.0001)。
  • PedSep-A患者(n=135,死亡率2%)更年轻且既往健康,C反应蛋白和铁蛋白水平最低,淋巴细胞和血小板计数最高,心率最高,肌酐最低(p<0.05)。
  • PedSep-B患者(n=102,死亡率12%)最可能需要插管且GCS最低;PedSep-C患者(n=110,死亡率10%)体温和GCS最高,肺衰竭最少,淋巴细胞计数最低(p<0.05)。

适用人群与场景

  • 儿童脓毒症患者,来自PHENOMS队列的404例儿童。

研究设计与关键结果

  • 研究类型:对现有PHENOMS数据集进行共识k-means聚类分析,样本量404例儿童,使用25个床旁变量(包括C反应蛋白和铁蛋白)推导24小时可计算表型。
  • 推导出四种表型:PedSep-A(n=135,死亡率2%)、PedSep-B(n=102,死亡率12%)、PedSep-C(n=110,死亡率10%)、PedSep-D(n=56,死亡率34%)。
  • PedSep-A患者更年轻且既往健康,C反应蛋白和铁蛋白水平最低,淋巴细胞和血小板计数最高,心率最高,肌酐最低(p<0.05)。
  • PedSep-B患者最可能需要插管且GCS最低(p<0.05)。
  • PedSep-C患者体温和GCS最高,肺衰竭最少,淋巴细胞计数最低(p<0.05)。
  • PedSep-D患者肌酐和器官衰竭数量最高,包括肾、肝和血液系统器官衰竭,血小板计数最低(p<0.05)。
  • PedSep-D发生TAMOF的校正OR为47.51(95%CI 18.83-136.83,p<0.0001),发生MAS的校正OR为38.63(95%CI 13.26-137.75,p<0.0001)。
  • 提供了计算机工具(www.pedsepsis.pitt.edu)用于识别个体患者表型归属。

证据类型、等级与局限

  • 证据类型:对现有队列数据集的二次分析(聚类分析)。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • PedSep-D表型患者发生TAMOF和MAS的风险高,作者认为该表型最适合入组针对TAMOF和MAS的早期个体化抗炎试验。
  • 提供了计算机工具(www.pedsepsis.pitt.edu)用于识别个体患者表型归属。
  • 可重复性将在两项正在进行的儿童脓毒症研究完成后评估。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Thrombotic microangiopathy-induced thrombocytopenia-associated multiple organ failure and hyperinflammatory macrophage activation syndrome are important causes of late pediatric sepsis mortality that are often missed or have delayed diagnosis. The National Institutes of General Medical Science sepsis research working group recommendations call for application of new research approaches in extant clinical data sets to improve efficiency of early trials of new sepsis therapies. Our objective is to apply machine learning approaches to derive computable 24-h sepsis phenotypes to facilitate personalized enrollment in early anti-inflammatory trials targeting these conditions.

METHODS: We applied consensus, k-means clustering analysis to our extant PHENOtyping sepsis-induced Multiple organ failure Study (PHENOMS) dataset of 404 children. 24-hour computable phenotypes are derived using 25 available bedside variables including C-reactive protein and ferritin.

RESULTS: Four computable phenotypes (PedSep-A, B, C, and D) are derived. Compared to all other phenotypes, PedSep-A patients (n = 135; 2% mortality) were younger and previously healthy, with the lowest C-reactive protein and ferritin levels, the highest lymphocyte and platelet counts, highest heart rate, and lowest creatinine (p < 0.05); PedSep-B patients (n = 102; 12% mortality) were most likely to be intubated and had the lowest Glasgow Coma Scale Score (p < 0.05); PedSep-C patients (n = 110; mortality 10%) had the highest temperature and Glasgow Coma Scale Score, least pulmonary failure, and lowest lymphocyte counts (p < 0.05); and PedSep-D patients (n = 56, 34% mortality) had the highest creatinine and number of organ failures, including renal, hepatic, and hematologic organ failure, with the lowest platelet counts (p < 0.05). PedSep-D had the highest likelihood of developing thrombocytopenia-associated multiple organ failure (Adj OR 47.51 95% CI [18.83-136.83], p < 0.0001) and macrophage activation syndrome (Adj OR 38.63 95% CI [13.26-137.75], p < 0.0001).

CONCLUSIONS: Four computable phenotypes are derived, with PedSep-D being optimal for enrollment in early personalized anti-inflammatory trials targeting thrombocytopenia-associated multiple organ failure and macrophage activation syndrome in pediatric sepsis. A computer tool for identification of individual patient membership ( www.pedsepsis.pitt.edu ) is provided. Reproducibility will be assessed at completion of two ongoing pediatric sepsis studies.

来源:Crit Care,查看原文。版权归原作者所有。

参考来源

  1. Qin Y, Kernan KF, Fan Z, et al. Machine learning derivation of four computable 24-h pediatric sepsis phenotypes to facilitate enrollment in early personalized anti-inflammatory clinical trials. Crit Care. 2022. PMID: 35526000. doi:10.1186/s13054-022-03977-3

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。